Verastem, Inc. has grown revenue 147% a year over three years and 1.7% a year over five. Revenue growth, 3-year annual rate: +147% (Biotechnology median +17%). Revenue growth, 5-year rate: +1.7%, growth has picked up over the last three years. Years of annual history on file: 15, FY2011 to FY2025, as filed.

VSTMVerastem, Inc.

Healthcare

$3.45-24% 1Y

$3.45

$3.4552 weeks$10.64

Is it growing?

Good

Growing: revenue growing +3996% year on year and operating margin widening (+187320.4 points).

2 good, 1 without data

Revenue trend+3996% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +2% a year.

Margin direction+187320.4 points operating

Trailing-twelve-month operating margin, -230.2% now against -187550.6% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is VSTM growing?

Verastem, Inc. has grown revenue 147% a year over three years and 1.7% a year over five.

+147%

Revenue growth, 3-year annual rate · Biotechnology median +17% · compounding fast · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: +1.7%
Revenue growth, 5-year rate · +147% over three · growth has picked up over the last three years
Years of annual history on file: 15
Years of annual history on file · FY2011 to FY2025, as filed

Details›